Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Oak Woods Acquisition | OAKU | Nov 25, 2024 | 11.36 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Nov 25, 2024 | 10.12 | 0.00 |
Oaktree Capital A Pref | OAK-A | Nov 25, 2024 | 23.67 | +0.46 |
Oaktree Capital Group B Pref | OAK-B | Nov 25, 2024 | 22.96 | +1.38 |
Oaktree Specialty | OCSL | Nov 25, 2024 | 16.02 | +1.07 |
Oatly ADR | OTLY | Nov 25, 2024 | 0.74 | +1.19 |
Oblong | OBLG | Nov 25, 2024 | 3.48 | +2.65 |
Occidental Petroleum | OXY | Nov 25, 2024 | 50.44 | -2.87 |
Ocean Biomedical | OCEA | Nov 25, 2024 | 0.70 | -2.78 |
Ocean Power Technologies | OPTT | Nov 25, 2024 | 0.18 | +14.96 |
Oceaneering International | OII | Nov 25, 2024 | 29.80 | -0.77 |
OceanFirst Financial | OCFC | Nov 25, 2024 | 21.27 | +1.87 |
OceanFirst Pref | OCFCP | Nov 25, 2024 | 25.20 | 0.00 |
OceanPal | OP | Nov 25, 2024 | 1.43 | -0.35 |
Ocugen | OCGN | Nov 25, 2024 | 0.92 | +1.63 |
Ocular Therapeutix | OCUL | Nov 25, 2024 | 9.09 | +2.94 |
Oculis | OCS | Nov 25, 2024 | 14.79 | +0.20 |
Ocuphire Pharma | OCUP | Nov 25, 2024 | 1.17 | 0.00 |
Oddity Tech | ODD | Nov 25, 2024 | 48.05 | +5.47 |
Odyssey Marine Exploration | OMEX | Nov 25, 2024 | 0.38 | -3.94 |
Offerpad Solutions A | OPAD | Nov 25, 2024 | 4.14 | +1.47 |
Office Properties | OPI | Nov 25, 2024 | 1.65 | +44.74 |
OFG Bancorp | OFG | Nov 25, 2024 | 46.72 | +2.64 |
OFS Capital | OFS | Nov 25, 2024 | 8.12 | -0.37 |
OFS Credit | OCCI | Nov 25, 2024 | 7.14 | +0.42 |
OFS Credit C Pref | OCCIO | Nov 25, 2024 | 24.82 | +0.65 |
OFS Credit Company Pref F | OCCIM | Nov 25, 2024 | 25.06 | 0.00 |
OFS Credit E Pref | OCCIN | Nov 25, 2024 | 23.85 | 0.00 |
OGE Energy | OGE | Nov 25, 2024 | 43.85 | +0.09 |
Ohio Valley Bank | OVBC | Nov 25, 2024 | 27.00 | -2.70 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.